164 related articles for article (PubMed ID: 12629150)
21. fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous fasL-expressing T cells.
Williams JF; Petrus MJ; Wright JA; Husebekk A; Fellowes V; Read EJ; Gress RE; Fowler DH
Br J Haematol; 1999 Oct; 107(1):99-105. PubMed ID: 10520029
[TBL] [Abstract][Full Text] [Related]
22. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
23. Fas/APO-1 gene transfer for human malignant glioma.
Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
[TBL] [Abstract][Full Text] [Related]
24. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
25. Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction.
Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Yoshida N; Nakayama K
J Immunol; 2002 Nov; 169(9):4732-8. PubMed ID: 12391181
[TBL] [Abstract][Full Text] [Related]
26. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors.
Hohlbaum AM; Gregory MS; Ju ST; Marshak-Rothstein A
J Immunol; 2001 Dec; 167(11):6217-24. PubMed ID: 11714783
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions.
Leuenroth S; Lee C; Grutkoski P; Keeping H; Simms HH
Surgery; 1998 Aug; 124(2):409-17. PubMed ID: 9706166
[TBL] [Abstract][Full Text] [Related]
28. Fas ligand-induced apoptosis as a mechanism of immune privilege.
Griffith TS; Brunner T; Fletcher SM; Green DR; Ferguson TA
Science; 1995 Nov; 270(5239):1189-92. PubMed ID: 7502042
[TBL] [Abstract][Full Text] [Related]
29. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.
Rescigno M; Piguet V; Valzasina B; Lens S; Zubler R; French L; Kindler V; Tschopp J; Ricciardi-Castagnoli P
J Exp Med; 2000 Dec; 192(11):1661-8. PubMed ID: 11104808
[TBL] [Abstract][Full Text] [Related]
30. Fas ligand on tumor cells mediates inactivation of neutrophils.
Chen YL; Chen SH; Wang JY; Yang BC
J Immunol; 2003 Aug; 171(3):1183-91. PubMed ID: 12874204
[TBL] [Abstract][Full Text] [Related]
31. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages.
Park DR; Thomsen AR; Frevert CW; Pham U; Skerrett SJ; Kiener PA; Liles WC
J Immunol; 2003 Jun; 170(12):6209-16. PubMed ID: 12794152
[TBL] [Abstract][Full Text] [Related]
32. Independent contributions of GR-1+ leukocytes and Fas/FasL interactions to induce apoptosis following interleukin-12 gene therapy in a metastatic model of prostate cancer.
Sanford MA; Yan Y; Canfield SE; Hassan W; Selleck WA; Atkinson G; Chen SH; Hall SJ
Hum Gene Ther; 2001 Aug; 12(12):1485-98. PubMed ID: 11506692
[TBL] [Abstract][Full Text] [Related]
33. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
Fecho K; Cohen PL
J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
[TBL] [Abstract][Full Text] [Related]
34. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
35. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Fas antigen (Fas, CD95)-mediated apoptosis of bovine granulosa cells by serum and growth factors.
Quirk SM; Harman RM; Cowan RG
Biol Reprod; 2000 Nov; 63(5):1278-84. PubMed ID: 11058530
[TBL] [Abstract][Full Text] [Related]
37. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
Xu T; Sun BC; Li Q; Hao XS
World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity.
Chung CS; Song GY; Lomas J; Simms HH; Chaudry IH; Ayala A
J Leukoc Biol; 2003 Sep; 74(3):344-51. PubMed ID: 12949237
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis in glioma cells by recombinant human Fas ligand.
Kawaguchi S; Mineta T; Ichinose M; Masuoka J; Shiraishi T; Tabuchi K
Neurosurgery; 2000 Feb; 46(2):431-8; discussion 438-9. PubMed ID: 10690733
[TBL] [Abstract][Full Text] [Related]
40. Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells.
Frassanito MA; Silvestris F; Silvestris N; Cafforio P; Camarda G; Iodice G; Dammacco F
Clin Exp Immunol; 1998 Nov; 114(2):179-88. PubMed ID: 9822274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
